Clinical Burden of Symptomatic HEV-3 Infection in Southern Spain.

doi:10.1111/apt.70790

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Clinical Burden of Symptomatic HEV-3 Infection in Southern Spain.

Alimentary pharmacology & therapeutics - 1 Sept 2026

Casares-Jimenez María, Ferreira-Tata Claudia, Viciana Isabel, Freyre-Carrillo Carolina, Lopez-Lopez Pedro, Perez Ana Belen, Becerril-Carral Berta, Fuentes Ana, Macías Juan, Rios-Muñoz Lucia, de Luna Francisco Franco-Alvarez, Cabezas-Fernandez María Teresa, Corona-Mata Diana, Rivero-Juarez Antonio, Rivero Antonio

Abstract excerpt

BACKGROUND: Hepatitis E virus genotype 3 (HEV-3) is a major cause of acute hepatitis in Europe. However, the clinical burden of symptomatic infection in routine practice and the relative contribution of host and viral factors to disease severity remain incompletely defined. We aimed to characterise the clinical burden, molecular epidemiology and determinants of adverse outcomes in patients with symptomatic HEV-3...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis E

Share to Hepatitis E virus

Share to Hospitalization

Share to RNA, Viral

Share to Severity of Illness Index

Share to Spain

Source

Open in PubMed Open full text

Identifiers

PMID: 42281445
DOI: 10.1111/apt.70790
PMCID: PMC13511309

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.